APPLICATIONS PUBLISHED 10 MARCH 2004
Published: 1-Sep-2004
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Use of follistatin to increase muscle mass
The Johns Hopkins University 1395113*
Pharmaceutical dispensing apparatus and method
Hewlett-Packard 1395223*
Tamper resistant oral dosage form
Euro-Celtique 1395224*
Dosing stick containing rod-shaped tablets
Schomakers, Juergen; Grummel, Andreas 1395225*
Use of radiopharmaceutical complexes in achieving transplantation tolerance
University of Miami 1395226*
Methods and compounds for the diagnosis of inflammatory disease and identification of pharmacological agents useful in the treatment of inflammatory disease
Boehringer Ingelheim Pharmaceuticals 1395227*
Modification of the sustained release profile
Alkernes Controlled Therapeutics 1395240*
Implantable medical device with controllable gaseous agent release system
Medtronic 1395241*
Liquid pharmaceutical compsn
Warner-Lambert 1395242*
Encapsulation of nanosuspensions in liposomes and microspheres
SkyePharma 1395243*
Oxidised collagen formulations for use with non-compatible pharmaceutical agents
Matrix Pharmaceuticals 1395244*
Foamed sol-gel and method of manufacturing the same
Imperial College Innovations; Sepulveda, Pilar 1395245*
Biocompatible compsns as carriers or excipients for pharmaceutical and nutraceutical formulations and for food protection
Institut National de la Recherche Scientifique; Universite du Quebec a Montreal 1395246*
Oxycarbazepine dosage forms
Ranbaxy Laboratories 1395247*
Fluid delivery device and associated method
Microlin 1395248*
Soft elastic capsules comprising ritonavir and/or lopinavir
Abbott Laboratories 1395249*
Surface-doped plaster containing an active ingredient
Beiersdorf 1395250*
Aminediols as agents for the treatment of Alzheimer's disease
Elan Pharmaceuticals 1395251*
Medicaments for treating colics
Bennetts the Chemist (Proprietary) 1395252*
Treatment of anxiety disorders
Eli Lilly 1395253*
Oral pharmaceutical compsn containing a statin derivative
Galephar M/F 1395254*
CDDO-compounds and combination therapies thereof
Board of Regents, the University of Texas System; Trustees of Dartmouth College 1395255*
Prodrugs via acylation with cinnamate
CryoLife 1395256*
Macrocycles useful in the treatment of Alzheimer's disease
Elan Pharmaceuticals; Pharmacia & Upjohn 1395257*
Oral controlled release pharmaceutical compsn for one-a-day therapy for the treatment and prophylaxis or cardiac and circulatory diseases
Sun Pharmaceuticals Industries 1395258*
Urazole compounds useful as anti-inflammatory agents
Bristol-Myers Squibb; Cerep 1395259*
Use of the opioid antagonist naltrexone to prevent and control side effects caused by opioids
Valpharma 1395260*
Pyridylpyrimidine derivatives as effective compounds against prion diseases
Axxima Pharmaceuticals 1395261*
Nucleoside vaccine adjuvants
Ribapharm 1395262*
3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure
Allergan 1395263*
Targeted delivery of drugs for the treatment of parasitic infections
Faulk, Ward Page 1395264*
Combretastatin A-3 prodrug
Arizona Board of Regents 1395265*
Antiviral nucleoside derivatives
F Hoffmann-La Roche 1395266*
Therapeutic compounds for modulating the immune response in a mammal and use thereof
University of Bath 1395267*
A method of implanting heavy metal such as noble metal e.g. gold, and metal for use in implantation
Danscher, Gorm 1395268*
Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
Societe des Produits Nestle 1395269*
Use of phyllanthus constituents for treating or preventing infections caused by hepatitis B
Phytrix 1395270*
Herbal compsns for the treatment of mucosal lesions
Herbal Synthesis 1395271*
Methods and compsns for inhibiting thrombin-induced coagulation
The Texas A&M University System 1395272*
Targeted delivery of drugs for the treatment or viral infections
Faulk, Page; Faulk Pharmaceuticals 1395273*
Compsns and methods for inhibiting metastasis
Duke University 1395274*
Beta-secretase substrates and uses thereof
Merck 1395275*
Structurally modified peptides and uses thereof
Ludwig Institutes for Cancer Research 1385276*
The use of gatran for the manufacture of a medicament for the treatment of pulmonary fibrosis
AstraZeneca 1395277*
Ocular tear growth factor-like protein
University of West Virginia Patent Foundation 1395278*
Use of neublastin polypeptides for treating neuropathic pain
Biogen 1395279*
Compsn and methods for affecting metallocorrinoid uptake
The Cleveland Clinic Foundation 1395280*
Recombinant MHC molecules useful for manipulation of antigen-specific T-cells
Oregon Health and Science University 1395281*
Vaccine complex for preventing or treating leishmaniasis
Bio-Veto Tests 1395282*
Heterologous protection induced by immunisation with invaplex vaccine
Walter Reed Army Institute of Research 1395283*
CD4-specific antibody TRX1 and uses therefor
Isis Innovation; Cambridge University Technical Services; Tolerrx 1395284*
Reagents and methods for modulating DKK-mediated interactions
Genome Therapeutics; Wyeth 1395285*
Pharmaceutical combination comprising an anti-androgen and an oestrogen receptor beta agonist
AstraZeneca 1395286*
An adenosine A2A receptor agonist and an anticholinergic agent in combination for treating obstructive airways diseases
Pfizer 1395287*
A PDE4 inhibitor and an anticholinergic agent in combination for treating obstructive airways diseases
Pfizer 1395288*
Treatment of neuropathic pain with a N-methyl-D-aspartate (NMDA) receptor antagonists
The General Hospital Corporation 1395289*
Cytotoxic CD44 antibody immunoconjugates
Boehringer Ingelheim 1395290*
Novel nucleic acids and their therapeutic use in ophthalmology
Malecaze, Francois 1395291*
Vectors for enhanced expression of VEGF for disease treatment
Fornix Biosciences 1395292*
Lentiviral vectors encoding clotting factors for gene therapy
Cell Genesys 1395293*
Pulmonary administration of chemically modified insulin
Nektar Therapeutics 1395294*
Process for the preparation of amorphous cilastatin sodium
Ranbaxy Laboratories 1395530*
Vitamin D analogues
Galderma Research and Development 1395538*
Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulphuric acid diamide and their use as medicaments
4SC 1395548*
Compounds and methods for preparing methanesulphonamides
Pharmacia & Upjohn 1395549*
Cycloalkenylsulphonamide derivatives
Eli Lilly 1395550*
Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of Alzheimer's disease and similar diseases
Elan Pharmaceuticals; Pharmacia & Upjohn 1395551*
